It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nanotechnology enlightens promising antibacterial strategies while the complex in vivo infection environment poses a great challenge to the rational design of nanoplatforms for safe and effective anti-infective therapy. Herein, a biomimetic nanoplatform (EV-Pd-Pt) integrating electrodynamic Pd-Pt nanosheets and natural ginger-derived extracellular vesicles (EVs) is proposed. The introduction of ginger-derived EVs greatly endows EV-Pd-Pt with prolonged blood circulation without immune clearance, as well as accumulation at infection sites. More interestingly, EV-Pd-Pt can enter the interior of bacteria in an EV lipid-dependent manner. At the same time, reactive oxygen species are sustainably generated in situ to overcome the limitations of their short lifetime and diffusion distance. Notably, EV-Pd-Pt nanoparticle-mediated electrodynamic and photothermal therapy exhibit synergistic effects. Furthermore, the desirable biocompatibility and biosafety of the proposed nanoplatform guarantee the feasibility of in vivo applications. This proof-of-concept work holds significant promise for developing biomimetic nanoparticles by exploiting their intrinsic properties for synergistic anti-infective therapy.
Antibacterial materials often suffer from issues around safety and application in complex in vivo environments. Here the authors report on the conjugation of electro-driven catalytic Pd-Pt nanosheets on ginger-derived extracellular vesicles for bacterial uptake and synergistic antibacterial therapy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Beijing University of Chemical Technology, State Key Laboratory of Chemical Resource Engineering, Beijing, China (GRID:grid.48166.3d) (ISNI:0000 0000 9931 8406); Key Laboratory of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology), Ministry of Education, Beijing, China (GRID:grid.419897.a) (ISNI:0000 0004 0369 313X); Beijing University of Chemical Technology, Beijing Laboratory of Biomedical Materials, Beijing, China (GRID:grid.48166.3d) (ISNI:0000 0000 9931 8406)
2 Beijing University of Chemical Technology, State Key Laboratory of Organic-Inorganic Composites, Beijing, China (GRID:grid.48166.3d) (ISNI:0000 0000 9931 8406)